KREMEN2 and non-small cell lung carcinoma: However, our results show that the knockdown of Kremen2 in NSCLC did not affect the PI3K and AKT protein levels, but only decreased the PI3K and AKT phosphorylation levels (Fig. 4E and Fig. S5).